Drugmaker Alexion to buy biotech Achillion in $930 mln deal
October 16, 2019 at 06:41 AM EDT
Alexion Pharmaceuticals Inc on Wednesday agreed to buy small biotech Achillion Pharmaceuticals Inc in a $930 million deal, to boost its pipeline of rare disease treatments.
